Reduction of the severity of 3'-azido-3'-deoxythymidine-induced anemia using a combination of benzylacyclouridine and dipyridamole
US4950466A · kind A · utility
9Cited by
0References
6Claims
0Family size
Inventors
Key dates
| Filing date | Jun 22, 1988 |
| Grant date | Aug 21, 1990 |
| Priority date | — |
| Expiry date | Jun 22, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a method of inhibiting anemia caused by the administration of AZT to a patient which comprises administering to said patient an effective anemia-inhibiting amount of a combination of dipyridamole and 5-benzylacyclouridine. The invention is further directed to a pharmaceutical composition comprising as the active pharmaceutical agent a combination of dipyridamole and 5-benzylacyclouridine in association with a pharmaceutically acceptable carrier or diluent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.